EGFR and neoplasm: The epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), the preferred heterodimer partner of EGFR, are cell surface receptor tyrosine kinases (RTK), and their activation promotes tumor cell proliferation.